Rheumatic heart disease Clinical Trials

7 recruitingLast updated: July 25, 2026

There are 7 actively recruiting rheumatic heart disease clinical trials across 7 countries. Studies span Not Applicable, Phase 3. Top locations include Addis Ababa, Ethiopia, Bergen, Norway, Kampala, UG, Uganda. Updated daily from ClinicalTrials.gov.


Rheumatic heart disease Trials at a Glance

7 actively recruiting trials for rheumatic heart disease are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Addis Ababa, Bergen, and Kampala. Lead sponsors running rheumatic heart disease studies include Children's Hospital Medical Center, Cincinnati, Helse Nord-Trøndelag HF, and Insel Gruppe AG, University Hospital Bern.

Browse rheumatic heart disease trials by phase

Treatments under study

About Rheumatic heart disease Clinical Trials

Looking for clinical trials for Rheumatic heart disease? There are currently 15 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Rheumatic heart disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Rheumatic heart disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 3

A Non-Inferiority Trial of Stopping Penicillin in Early Rheumatic Heart Disease: GOAL-Stop

Rheumatic heart disease
Children's Hospital Medical Center, Cincinnati922 enrolled1 locationNCT07146048
Recruiting
Not Applicable

Accelerating Delivery of rheUmatic Heart Disease Preventive iNterventions in Northern Uganda

Rheumatic heart disease
Children's Hospital Medical Center, Cincinnati221 enrolled1 locationNCT05783375
Recruiting
Not Applicable

School-based Program for the Prevention of Rheumatic Heart Disease in Endemic Regions

Rheumatic Heart Disease in Children
Thomas Pilgrim6,000 enrolled2 locationsNCT06720272
Recruiting

The Clinical Influence of Developing a Sustainable Cardiac Surgery Service to Reduce the Burden of Rheumatic Heart Disease in Sub-Saharan Africa

Rheumatic heart diseaseAnticoagulant Adverse Reaction
Helse Nord-Trøndelag HF200 enrolled4 locationsNCT04556188
Recruiting
Not Applicable

Treating Severe Mitral Valve Annular or Valvular Calcification Using Shockwave Balloon SMARTWAVE

Rheumatic heart diseaseMitral Annulus Calcification
Prince of Wales Hospital, Shatin, Hong Kong10 enrolled1 locationNCT06952374
Recruiting

Screening and Secondary Prevention Rheumatic Heart Disease Study

Rheumatic heart disease
National Institute of Cardiovascular Diseases, Pakistan5,000 enrolled1 locationNCT05991219
Recruiting
Not Applicable

Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease

Rheumatic heart diseaseRheumatic Heart Disease in Children
Insel Gruppe AG, University Hospital Bern2,300 enrolled1 locationNCT05504928